Department of Medicine, Harbor Hospital, Baltimore, MD, USA.
Mayo Clin Proc. 2012 Oct;87(10):953-60. doi: 10.1016/j.mayocp.2012.05.020. Epub 2012 Sep 12.
To determine the association between asthma and proinflammatory conditions.
This population-based retrospective matched cohort study enrolled all asthmatic patients among Rochester, Minnesota, residents between January 1, 1964, and December 31, 1983. For each asthmatic patient, 2 age-and sex-matched nonasthmatic individuals were drawn from the same population. The asthmatic and nonasthmatic cohorts were followed forward in the Rochester Epidemiology Project diagnostic index for inflammatory bowel disease (IBD), rheumatoid arthritis (RA), diabetes mellitus (DM), and coronary heart disease (CHD) as outcome events. Data were fitted to Cox proportional hazards models.
We identified 2392 asthmatic patients and 4784 nonasthmatic controls. Of the asthmatic patients, 1356 (57%) were male, and mean age at asthma onset was 15.1 years. Incidence rates of IBD, RA, DM, and CHD in nonasthmatic controls were 32.8, 175.9, 132.0, and 389.7 per 100,000 person-years, respectively; those for asthmatic patients were 41.4, 227.9, 282.6, and 563.7 per 100,000 person-years, respectively. Asthma was associated with increased risks of DM (hazard ratio, 2.11; 95% confidence interval, 1.43-3.13; P<.001) and CHD (hazard ratio, 1.47; 95% confidence interval, 1.05-2.06; P=.02) but not with increased risks of IBD or RA.
Although asthma is a helper T cell type 2-predominant condition, it may increase the risks of helper T cell type 1-polarized proinflammatory conditions, such as CHD and DM. Physicians who care for asthmatic patients need to address these unrecognized risks in asthmatic patients.
确定哮喘与促炎状态之间的关联。
本基于人群的回顾性匹配队列研究纳入了 1964 年 1 月 1 日至 1983 年 12 月 31 日期间罗切斯特市明尼苏达州居民中的所有哮喘患者。对于每例哮喘患者,从同一人群中抽取 2 名年龄和性别匹配的非哮喘个体。将哮喘和非哮喘队列在罗切斯特流行病学项目炎症性肠病(IBD)、类风湿关节炎(RA)、糖尿病(DM)和冠心病(CHD)的诊断索引中进行前瞻性随访,作为结局事件。数据采用 Cox 比例风险模型进行拟合。
我们确定了 2392 例哮喘患者和 4784 名非哮喘对照者。在哮喘患者中,1356 例(57%)为男性,哮喘发病时的平均年龄为 15.1 岁。非哮喘对照者中 IBD、RA、DM 和 CHD 的发生率分别为 32.8、175.9、132.0 和 389.7/10 万人年;哮喘患者中的发生率分别为 41.4、227.9、282.6 和 563.7/10 万人年。哮喘与 DM(风险比,2.11;95%置信区间,1.43-3.13;P<.001)和 CHD(风险比,1.47;95%置信区间,1.05-2.06;P=.02)的风险增加相关,但与 IBD 或 RA 的风险增加无关。
尽管哮喘是一种辅助性 T 细胞 2 型为主的疾病,但它可能增加辅助性 T 细胞 1 型为主的促炎状态的风险,如 CHD 和 DM。照顾哮喘患者的医生需要在哮喘患者中解决这些未被认识到的风险。